Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-13

FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for cyclobenzaprine hydrochloride (Upsher-Smith Laboratories, LLC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOBENZAPRINE HYDROCHLORIDE (Cyclobenzaprine hydrochloride)

Snippet

SUPPL AP for CYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE HYDROCHLORIDE)